Neuronal programmed cell death (PCD) contributes to delayed tissue damage after traumatic brain injury (TBI). Both caspase-dependent and caspase-independent mechanisms have been implicated, with the latter including apoptosis inducing factor (AIF). The peptidyl-proplyl isomerase Cyclophilin A (CypA) transports AIF from the cytosol to the nucleus, a key step for AIF-dependent cell death. We compared the effects of single versus combined inhibition of caspase and AIF pathways in a mouse controlled cortical impact (CCI) model, by examining the effects of CypA gene knockout (CypA −/− ), caspase inhibition with a pan-caspase inhibitor ) reduced the number of apoptotic cells (TUNEL-positive) in the cortex and improved long-term sensorimotor function; CypA −/− also attenuated microglial activation after injury. Importantly, BAF-treated CypA −/− mice, showed greater effects than either intervention alone on multiple outcomes including: reduction in TUNEL-positive cells, decrease in neuroinflammation, improved motor and cognitive recovery, and attenuation of lesion volume and neuronal loss in the hippocampus. Using two in vitro neuronal cell death models known to induce AIF-mediated PCD, we also showed that neurons from CypA −/− animals were protected and that effects were unrelated to caspase activation. These data indicate that AIF-mediated and caspase-dependent pathways contribute independently and in parallel to secondary injury after TBI, and suggest that combined therapeutic strategies directed at multiple PCD pathways may provide superior neuroprotection than those directed at single mechanisms.
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Introduction
Traumatic brain injury (TBI) is a major public health problem in the United States, with more than 1.7 million new cases every year (Faul et al., 2010) and accounting for 60% of all trauma deaths (Dutton et al., 2010) . In spite of significant effort there is still no effective treatment for clinical TBI (Faden and Stoica, 2007; Stoica et al., 2009a) . TBI causes cell death and neurological dysfunction through both direct physical disruption of tissue or pathways (primary injury), and through subsequent biochemical changes (secondary injury); the latter represents delayed and potentially reversible molecular and cellular pathophysiological mechanisms (Stoica and Faden, 2010) . Delayed neuronal cell death is a key element of the secondary injury, reflecting various types of neuronal programmed cell death (PCD) and contributes significantly to post-traumatic neurological deficits in experimental TBI (Stoica and Faden, 2010; Yakovlev et al., 2001) . Both caspase-dependent and caspase-independent types of PCD contribute to such neuronal loss (Stoica and Faden, 2010) . Caspase-mediated apoptosis was initially proposed as an important PCD pathway involved, based upon the demonstration of caspase activation in experimental TBI models and neuroprotection shown with selective caspase inhibitors (Knoblach et al., 2002; Yakovlev et al., 1997) . Subsequent studies suggested involvement of additional potential PCD mechanisms, such as the translocation of apoptosis inducing factor (AIF) (Slemmer et al., 2008; Tomita et al., 2006; Tweedie et al., 2007; Zhang et al., 2002) .
